A detailed history of Vontobel Holding Ltd. transactions in Incyte Corp stock. As of the latest transaction made, Vontobel Holding Ltd. holds 12,411 shares of INCY stock, worth $890,116. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,411
Previous 13,256 6.37%
Holding current value
$890,116
Previous $803,000 2.12%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$57.33 - $68.61 $48,443 - $57,975
-845 Reduced 6.37%
12,411 $820,000
Q2 2024

Aug 13, 2024

SELL
$51.18 - $63.75 $64,896 - $80,835
-1,268 Reduced 8.73%
13,256 $803,000
Q1 2024

May 10, 2024

SELL
$56.55 - $66.59 $142,562 - $167,873
-2,521 Reduced 14.79%
14,524 $827,000
Q4 2023

Jun 03, 2024

SELL
$52.16 - $64.19 $1,773 - $2,182
-34 Reduced 0.25%
13,321 $836,000
Q4 2023

Jan 29, 2024

BUY
$52.16 - $64.19 $18,829 - $23,172
361 Added 2.16%
17,045 $1.07 Million
Q3 2023

Jun 03, 2024

SELL
$57.77 - $65.93 $14,153 - $16,152
-245 Reduced 1.8%
13,355 $771,000
Q3 2023

Oct 10, 2023

BUY
$57.77 - $65.93 $11,265 - $12,856
195 Added 1.18%
16,684 $963,000
Q2 2023

Jun 03, 2024

BUY
$60.95 - $75.51 $27,793 - $34,432
456 Added 3.47%
13,600 $846,000
Q2 2023

Jul 24, 2023

BUY
$60.95 - $75.51 $27,793 - $34,432
456 Added 2.84%
16,489 $1.03 Million
Q1 2023

Jun 03, 2024

SELL
$70.23 - $86.01 $96,917 - $118,693
-1,380 Reduced 9.5%
13,144 $949,000
Q1 2023

Apr 12, 2023

BUY
$70.23 - $86.01 $390,970 - $478,817
5,567 Added 53.19%
16,033 $1.16 Million
Q4 2022

Feb 14, 2023

BUY
$67.18 - $84.11 $435,393 - $545,116
6,481 Added 162.63%
10,466 $840,000
Q3 2022

Nov 04, 2022

SELL
$66.18 - $82.86 $132,227 - $165,554
-1,998 Reduced 33.39%
3,985 $265,000
Q2 2022

Jul 27, 2022

BUY
$66.18 - $83.18 $46,127 - $57,976
697 Added 13.19%
5,983 $454,000
Q1 2022

May 13, 2022

SELL
$66.02 - $79.71 $700,604 - $845,882
-10,612 Reduced 66.75%
5,286 $422,000
Q4 2021

Feb 14, 2022

SELL
$63.34 - $74.11 $64,226 - $75,147
-1,014 Reduced 6.0%
15,898 $1.18 Million
Q3 2021

Oct 29, 2021

BUY
$68.67 - $84.02 $195,709 - $239,457
2,850 Added 20.27%
16,912 $1.16 Million
Q2 2021

Aug 06, 2021

BUY
$79.87 - $87.53 $106,866 - $117,115
1,338 Added 10.52%
14,062 $1.19 Million
Q1 2021

May 11, 2021

SELL
$76.02 - $100.5 $390,210 - $515,866
-5,133 Reduced 28.75%
12,724 $1.03 Million
Q4 2020

Feb 12, 2021

BUY
$80.74 - $97.7 $1.44 Million - $1.74 Million
17,857 New
17,857 $1.67 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.